Cost-effectiveness of pancreas surveillance: The CDKN2A-p16-Leiden cohort.

Isaura S IbrahimHans F A VasenMartin N J M WasserShirin FeshtaliBert A BonsingHans MorreauAkin IndersonWouter H de Vos Tot Nederveen CappelWilbert B van den Hout

Published in: United European gastroenterology journal (2023)

The tumor could be resected in most patients with a screen-detected PDAC. These patients had considerably better survival and as a result annual surveillance was found to be cost-effective.

Keyphrases

public health
end stage renal disease
prognostic factors
newly diagnosed
ejection fraction
lymph node
peritoneal dialysis
high throughput